Summary
This paper discusses the potential of Arylsulfatase B (ARSB) in enhancing retinal ganglion cell axon regeneration, which could be a potential treatment for optic nerve damage.
Categories
Eye health: The paper discusses the potential of ARSB in enhancing retinal ganglion cell axon regeneration, which could be a potential treatment for optic nerve damage.
Patient recovery and healing: The paper discusses the potential of ARSB in enhancing retinal ganglion cell axon regeneration, which could aid in the recovery and healing of patients with optic nerve damage.
Author(s)
CS Pearson
Publication Year
2018
Related Publications
Eye health
- Phototransduction by retinal ganglion cells that set the circadian clock
- Color appearance models
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Strange vision: ganglion cells as circadian photoreceptors
- Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa
Patient recovery and healing
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Understanding the effects of mild traumatic brain injury on the pupillary light reflex
- Injured adult retinal axons with Pten and Socs3 co-deletion reform active synapses with suprachiasmatic neurons
- The effect of light on critical illness
- Potential for the development of light therapies in mild traumatic brain injury